These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6765140

  • 1. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
    Herskovits E, Vazquez A, Famulari A, Tamaroff L, Fraiman H, Gonzáles AM, Smud R, Vila J, Matera V.
    Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
    [Abstract] [Full Text] [Related]

  • 2. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
    Herskovits E, Famulari A, Tamaroff L, Gonzalez AM, Vázquez A, Dominguez R, Fraiman H, Vila J.
    Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
    [Abstract] [Full Text] [Related]

  • 3. Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks.
    Herskovits E, Vazquez A, Famulari A, Smud R, Tamaroff L, Fraiman H, Gonzalez AM, Vila J, Matera V.
    Lancet; 1981 May 02; 1(8227):966-8. PubMed ID: 6112386
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of pentoxifylline vs antiaggregants in patients with transient ischaemic attacks.
    Herskovits E, Famulari A, Tamaroff L, Gonzalez AM, Vzquez A, Dominguez R, Fraiman H, Vila J, Benjamin V, Matera V.
    Acta Neurol Scand Suppl; 1989 May 02; 127():31-5. PubMed ID: 2631519
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 02; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 6. The European Stroke Prevention Study (ESPS): results by arterial distribution.
    Sivenius J, Riekkinen PJ, Smets P, Laakso M, Lowenthal A.
    Ann Neurol; 1991 Jun 02; 29(6):596-600. PubMed ID: 1892362
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ.
    Curr Med Res Opin; 2007 Jun 02; 23(6):1453-62. PubMed ID: 17559741
    [Abstract] [Full Text] [Related]

  • 8. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J.
    J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Smith EE, Cannon CP, Murphy S, Feske SK, Schwamm LH.
    Am Heart J; 2006 Feb 15; 151(2):338-44. PubMed ID: 16442896
    [Abstract] [Full Text] [Related]

  • 10. Dipyridamole-associated headache in stroke patients--interindividual differences?
    Lökk J.
    Eur Neurol; 2009 Feb 15; 62(2):109-13. PubMed ID: 19521087
    [Abstract] [Full Text] [Related]

  • 11. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
    Brechter C, Bäcklund H, Krook H, Müller R, Nitelius E, Olsson JE, Olsson O, Thornberg A.
    Lakartidningen; 1980 Dec 24; 77(52):4947-56. PubMed ID: 7010029
    [No Abstract] [Full Text] [Related]

  • 12. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP, Lodder J.
    Expert Rev Neurother; 2008 Nov 24; 8(11):1661-5. PubMed ID: 18986236
    [Abstract] [Full Text] [Related]

  • 13. Clinical inquiries. What is the best management for patients who have a TIA while on aspirin therapy?
    Ahmed N, Coffey JB, Oh R.
    J Fam Pract; 2006 Jul 24; 55(7):627-8. PubMed ID: 16822451
    [Abstract] [Full Text] [Related]

  • 14. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP, Saseen JJ.
    Pharmacotherapy; 2008 Oct 24; 28(10):1233-42. PubMed ID: 18823219
    [Abstract] [Full Text] [Related]

  • 15. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA.
    Am Fam Physician; 2005 Aug 01; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract] [Full Text] [Related]

  • 16. [Controlled cooperative trial. Secondary prevention of atherosclerosis-related cerebral ischemic accidents by aspirin dipyridamole. 2: Description of subjects at the beginning of the trial].
    Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Thibult N, Touboul D, Touboul PJ.
    Rev Neurol (Paris); 1982 Aug 01; 138(1):1-15. PubMed ID: 7048482
    [Abstract] [Full Text] [Related]

  • 17. [A preliminary report of treatment of transient cerebral ischemic attacks with BL 191 (author's transl)].
    Chen HB.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Feb 01; 13(2):97-9. PubMed ID: 7428559
    [No Abstract] [Full Text] [Related]

  • 18. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA, Chalakova NT, Dimitrov BD.
    Cerebrovasc Dis; 2008 Feb 01; 25(3):225-33. PubMed ID: 18216464
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC.
    Int J Stroke; 2006 Feb 01; 1(1):4-8. PubMed ID: 18706062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.